Taken together, these results indicated that ASA functioned through its transacetylation on chromatin directly or indirectly by modifying acetylation of nucleosomes/histones and/or DNA that altered the chromatin structure and accessibility, resulting in extensive changes of the epigenetic/biological processes in ESCC cells, especially pCSCs. The gene discussed is ARSA; the disease is esophageal squamous cell carcinoma.